Condition: Spinocerebellar Ataxia Type 27B · Sponsor: University Hospital Tuebingen
This international, multi-center, multi-modal, and prospective observational cohort study aims to validate trial outcomes for capturing disease progression in Spinocerebellar Ataxia Type 27B (SCA27B), with combined multi-modal capture of clinical outcome assessments, digital-motor assessments, and molecular biomarkers.
This description comes directly from the study's public registry record.
Matthis Synofzik, Prof. Dr. · +49 7071 29 · matthis.synofzik@uni-tuebingen.de
Andreas Traschütz, Dr. Dr. · +49 7071 29 · andreas.traschuetz@uni-tuebingen.de
Always discuss trial participation with your own doctor first.
| Department of Neurology, Motol University Hospital, Second Faculty of Medicine, Charles University | Prague, Czechia | Recruiting |
| Center for Neurology & Hertie-Institute for Clinical Brain Research, Dept. for Neurodegenerative Diseases | Tübingen, Baden-Wurttemberg, Germany | Recruiting |
| Department of Neurology & Center for Translational Neuro- and Behavioral Sciences, Essen University Hospital, University of Duisburg-Essen | Essen, North Rhine-Westphalia, Germany | Recruiting |
| IRCCS Fondazione Stella Maris | Pisa, Italy | Recruiting |
| Department of Neurology, Donostia University Hospital, BioGipuzkoa Health Research Institute | San Sebastián, Gipuzkoa, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06472557